The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 708K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, synthesis, and evaluation of new vanin-1 inhibitors based on RR6.EBI
Osaka Medical and Pharmaceutical University
Discovery of a Series of Pyrimidine Carboxamides as Inhibitors of Vanin-1.EBI
Pfizer
Novel Heteroaromatic Compounds as Vanin Inhibitors.EBI
Lauren Mccallister
TRICYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOFBDB
Shanghai Hansoh Biomedical
IMPROVED SELECTIVE JAK2 INHIBITORS AND METHODS OF USEBDB
Yale University
PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORSBDB
Chiesi Farmaceutici
KETOHEXOKINASE INHIBITOR AND USE THEREOFBDB
Sichuan Haisco Pharmaceutical Co.
Substituted [1,2,4]triazolo[4,3-a]pyrazines as antidiabeticsBDB
King Abdulaziz University
Modulators of the 5-hydroxytryptamine receptor 7 and their method of useBDB
Temple University
Heterocycles useful as IDO and TDO inhibitorsBDB
Hangzhou Innogate Pharma
Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells.BDB
National Tsing Hua University